Finance

Lists
Why is OKUR up 4,78%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
US$2,41
+4,78%
(+0,11) 1D
US$2,43
+0,83% (+0,020)
After hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
US$2,29
High
US$2,42
Low
US$2,23
Mkt. cap
97,60 ລ້ານ
Avg. vol.
311,73 ພັນ
Volume
609,37 ພັນ
52-wk high
US$5,38
52-wk low
US$2,13
EPS
US$-3,50
Beta
0,12
Shares outstanding
40,50 ລ້ານ
No. of employees
45
Open
US$2,29
High
US$2,42
Low
US$2,23
Mkt. cap
97,60 ລ້ານ
Avg. vol.
311,73 ພັນ
Volume
609,37 ພັນ
52-wk high
US$5,38
52-wk low
US$2,13
EPS
US$-3,50
Beta
0,12
Shares outstanding
40,50 ລ້ານ
No. of employees
45
News stories
From web sources and news partners
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
Headquartersເບົາເດີ, ໂຄໂລຣາໂດ, ສະຫະລັດ
SectorBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current US$2,41
US$21,00 (+771,37%)
Average
US$17,00 (+605,39%)
Lowest
US$14,00 (+480,91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$14,00
+480,9%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$14,00
+480,9%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
US$16,00
+563,9%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$21,00
+771,4%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$17,00
+605,4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,92 ລ້ານ
10,72 ລ້ານ
11,71 ລ້ານ
12,61 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 ລ້ານ
3,40 ລ້ານ
3,91 ລ້ານ
4,29 ລ້ານ
Operating expense
15,50 ລ້ານ
14,12 ລ້ານ
15,62 ລ້ານ
16,90 ລ້ານ
Total operating expenses
15,50 ລ້ານ
14,12 ລ້ານ
15,62 ລ້ານ
16,90 ລ້ານ
Operating income
-15,50 ລ້ານ
-14,12 ລ້ານ
-15,62 ລ້ານ
-16,90 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-14,70 ລ້ານ
-13,50 ລ້ານ
-15,16 ລ້ານ
-15,35 ລ້ານ
EBT excluding unusual items
-14,70 ລ້ານ
-13,50 ລ້ານ
-15,16 ລ້ານ
-15,35 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,70 ລ້ານ
-13,50 ລ້ານ
-15,16 ລ້ານ
-15,35 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-1,09
-0,99
-1,11
-0,31
Interest and investment income
804,00 ພັນ
628,00 ພັນ
458,00 ພັນ
1,55 ລ້ານ
Interest expense
-2,00 ພັນ
-6,00 ພັນ
-
-
Net interest expenses
802,00 ພັນ
622,00 ພັນ
458,00 ພັນ
1,55 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,39 ລ້ານ
-14,02 ລ້ານ
-15,51 ລ້ານ
-16,81 ລ້ານ
Gain or loss from assets sale
2,00 ພັນ
4,00 ພັນ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google